Illumina, Inc. income statement ILMN

Annual Quarterly

In fiscal 2025, which ended Dec 28, 2025, Illumina, Inc. reported revenue of $4.3 billion, down 0.7% from the year before. Net income was $850.0 million, a profit margin of 19.6%. Operating income came to $807.0 million, an operating margin of 18.6%. Diluted earnings per share were $5.45. Over the twelve months ended Sep 27, 2026, revenue was $4.5 billion and net income was $895.0 million. Across the 10 fiscal years shown, revenue grew from $2.4 billion in fiscal 2016 to $4.3 billion in fiscal 2025, about 6.8% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 27, 2026	FY 2025 Dec 28, 2025	FY 2024 Dec 29, 2024	FY 2023 Dec 31, 2023	FY 2022 Jan 1, 2023	FY 2021 Jan 2, 2022	FY 2020 Jan 3, 2021	FY 2019 Dec 29, 2019	FY 2018 Dec 30, 2018	FY 2017 Dec 31, 2017	FY 2016 Jan 1, 2017
Revenue	4,539 +5.9%	4,343 -0.7%	4,372 -2.9%	4,504 -1.7%	4,584 +1.3%	4,526 +39.7%	3,239 -8.6%	3,543 +6.3%	3,333 +21.1%	2,752 +14.8%	2,398 +8.0%
Cost of revenue	1,459 +0.7%	1,473 -2.5%	1,511 -14.1%	1,760 +9.2%	1,612 +17.5%	1,372 +32.4%	1,036 -3.7%	1,076 +4.2%	1,033 +11.6%	926 +26.5%	732 +9.1%
Gross profit	3,080 +8.5%	2,870 +0.3%	2,861 +4.3%	2,744 -7.7%	2,972 -5.8%	3,154 +43.2%	2,203 -10.7%	2,467 +7.3%	2,300 +26.0%	1,826 +9.6%	1,666 +7.6%
Research and development	975 -0.9%	967 -17.3%	1,169 -13.7%	1,354 +2.5%	1,321 +11.5%	1,185 +73.8%	682 +5.4%	647 +3.9%	623 +14.1%	546 +8.3%	504 +25.7%
Selling, general and administrative	1,135 +7.5%	1,086 -0.5%	1,092 -32.3%	1,612 +24.3%	1,297 -38.0%	2,092 +122.3%	941 +12.7%	835 +5.2%	794 +17.8%	674 +15.4%	584 +13.2%
Restructuring and impairment	—	47 -24.2%	62 -59.2%	152	—	—	—	—	—	—	—
Operating income	960 +22.9%	807 +196.9%	-833 +22.1%	-1,069 +74.4%	-4,179 -3297.6%	-123 -121.2%	580 -41.1%	985 +11.6%	883 +45.7%	606 +3.2%	587 -4.2%
Interest income	41 +2.5%	40 -13.0%	46 -20.7%	58 +427.3%	11	0 -100.0%	41 -45.3%	75 +70.5%	44 +131.6%	19 +90.0%	10 +100.0%
Interest expense	97 -3.0%	101 +1.0%	100	—	—	—	—	—	—	—	—
Other non-operating income (expense)	154 -12.0%	340 +216.4%	-292 -906.9%	-29 +79.6%	-142 -113.3%	1,068 +276.1%	284 +158.2%	110 +358.3%	24 -94.7%	455 +15266.7%	-3 +62.5%
Pretax income	1,058 +18.1%	1,086 +192.1%	-1,179 -5.6%	-1,117 +74.2%	-4,336 -590.5%	884 +3.3%	856 -23.4%	1,118 +25.1%	894 -14.3%	1,043 +85.9%	561 -3.8%
Income tax	163 -15.5%	236 +436.4%	44 +0.0%	44 -35.3%	68 -44.3%	122 -39.0%	200 +56.2%	128 +14.3%	112 -69.3%	365 +174.4%	133 +6.4%
Net income	895 +27.3%	850 +169.5%	-1,223 -5.3%	-1,161	—	762 +16.2%	656 -34.5%	1,002 +21.3%	826 +13.8%	726 +56.8%	463 +0.2%
Basic EPS	5.89 +31.3%	5.47 +171.1%	-7.69 -4.8%	-7.34 +73.8%	-28.00 -652.3%	5.07 +13.2%	4.48 -34.2%	6.81 +21.0%	5.63 +13.5%	4.96 +60.5%	3.09 -3.1%
Diluted EPS	5.82 +30.4%	5.45 +170.9%	-7.69 -4.8%	-7.34 +73.8%	-28.00 -655.6%	5.04 +13.3%	4.45 -34.0%	6.74 +21.2%	5.56 +13.0%	4.92 +60.3%	3.07 -1.0%
Weighted average shares, basic	152 -3.0%	155 -2.5%	159 +0.6%	158 +0.6%	157 +4.7%	150 +2.0%	147 +0.0%	147 +0.0%	147 +0.7%	146 -0.7%	147 +1.4%
Weighted average shares, diluted	154 -2.4%	156 -1.9%	159 +0.6%	158 +0.6%	157 +4.0%	151 +2.0%	148 -0.7%	149 +0.0%	149 +0.7%	148 +0.0%	148 -0.7%
Other measures
Depreciation and amortization	204 -1.4%	270 -23.7%	354 -18.1%	432 +9.6%	394 +57.0%	251 +34.2%	187 -0.5%	188 +5.0%	179 +14.7%	156 +10.6%	141 +93.2%
EBITDA	1,164 +17.8%	1,077 +324.8%	-479 +24.8%	-637 +83.2%	-3,785 -3057.0%	128 -83.3%	767 -34.6%	1,173 +10.5%	1,062 +39.4%	762 +4.7%	728 +6.1%
Interest coverage	9.90x	7.99x	-8.33x	—	—	—	—	—	—	—	—
Margins
Gross margin	67.86%	66.08%	65.44%	60.92%	64.83%	69.69%	68.01%	69.63%	69.01%	66.35%	69.47%
Operating margin	21.15%	18.58%	-19.05%	-23.73%	-91.16%	-2.72%	17.91%	27.80%	26.49%	22.02%	24.48%
Pretax margin	23.31%	25.01%	-26.97%	-24.80%	-94.59%	19.53%	26.43%	31.56%	26.82%	37.90%	23.39%
Profit margin	19.72%	19.57%	-27.97%	-25.78%	—	16.84%	20.25%	28.28%	24.78%	26.38%	19.31%
EBITDA margin	25.64%	24.80%	-10.96%	-14.14%	-82.57%	2.83%	23.68%	33.11%	31.86%	27.69%	30.36%
Effective tax rate	15.41%	21.73%	—	—	—	13.80%	23.36%	11.45%	12.53%	35.00%	23.71%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: ILMN (Nasdaq)
Fiscal year ends: January 3
Incorporated in: DE
Headquarters: San Diego, CA
SEC filer status: Large accelerated filer
SEC CIK: 1110803
Former names: ILLUMINA INC (until Aug 19, 2019)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.